ABIOMED Financial Statements From 2010 to 2024
ABIOMED financial statements provide useful quarterly and yearly information to potential ABIOMED investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on ABIOMED financial statements helps investors assess ABIOMED's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting ABIOMED's valuation are summarized below:ABIOMED does not at this time have any fundamental signals for analysis.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
Check ABIOMED financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ABIOMED's main balance sheet or income statement drivers, such as , as well as many indicators such as . ABIOMED financial statements analysis is a perfect complement when working with ABIOMED Valuation or Volatility modules.
ABIOMED |
ABIOMED Company Current Valuation Analysis
ABIOMED's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current ABIOMED Current Valuation | 16.32 B |
Most of ABIOMED's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ABIOMED is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, ABIOMED has a Current Valuation of 16.32 B. This is 13.62% higher than that of the Health Care Equipment & Supplies sector and 31.36% higher than that of the Health Care industry. The current valuation for all United States stocks is 1.83% higher than that of the company.
ABIOMED Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ABIOMED's current stock value. Our valuation model uses many indicators to compare ABIOMED value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ABIOMED competition to find correlations between indicators driving ABIOMED's intrinsic value. More Info.ABIOMED is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.52 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for ABIOMED is roughly 1.91 . Comparative valuation analysis is a catch-all technique that is used if you cannot value ABIOMED by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About ABIOMED Financial Statements
ABIOMED stakeholders use historical fundamental indicators, such as ABIOMED's revenue or net income, to determine how well the company is positioned to perform in the future. Although ABIOMED investors may analyze each financial statement separately, they are all interrelated. For example, changes in ABIOMED's assets and liabilities are reflected in the revenues and expenses on ABIOMED's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in ABIOMED. Please read more on our technical analysis and fundamental analysis pages.
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. The company was founded in 1981 and is headquartered in Danvers, Massachusetts. Abiomed operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 2003 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Consideration for investing in ABIOMED Stock
If you are still planning to invest in ABIOMED check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ABIOMED's history and understand the potential risks before investing.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |